Dr. Castro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4000 Cambridge St
MSN 3007
Kansas City, KS 66160Phone+1 913-588-7529Fax+1 913-535-2200
Summary
- Dr. Mario Castro is a pulmonologist in Kansas City, KS and is affiliated with The University of Kansas Health System. He received his medical degree from University of Missouri - Kansas City School of Medicine and has been in practice 29 years. He specializes in asthma & copd, critical care medicine, interventional pulmonology, and pleural disease and is experienced in asthma, chronic obstructive pulmonary disease, lymphangioleiomyomatosis, sarcoidosis, and airway remodeling.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1988 - 1991
- University of Missouri Kansas City School of MedicineClass of 1988
Certifications & Licensure
- MO State Medical License 1994 - 2026
- KS State Medical License 2019 - 2025
- FL State Medical License 1990 - 1994
- IA State Medical License 1991 - 1994
- MN State Medical License 1989 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Start of enrollment: 2004 Dec 01
- Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Start of enrollment: 2006 Jun 01
- Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEffect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, plac...Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira L Lugogo, Christopher E Brightling
The Lancet. Respiratory Medicine. 2025-03-01 - 2 citations2024 Update of the RECOVER-Adult Long COVID Research Index.Linda N Geng, Kristine M Erlandson, Mady Hornig, Rebecca Letts, Caitlin Selvaggi
JAMA. 2025-02-25 - Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma.Clarus Leung, Monica Tang, Walter E Finkbeiner, Mats W Johansson, Loren C Denlinger
American Journal of Respiratory and Critical Care Medicine. 2025-02-25
Press Mentions
- Dupilumab Boosts Lung Function in Patients with Type 2 AsthmaMarch 18th, 2025
- Ivermectin Shown Ineffective in Treating COVID-19, According to Multi-Site Study Including KU Medical CenterDecember 1st, 2022
- American College of Chest Physicians, Oct. 16-19October 31st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: